Literature DB >> 9271412

Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts.

N Takuwa1, Y Takuwa.   

Abstract

It is well documented that Ras functions as a molecular switch for reentry into the cell cycle at the border between G0 and G1 by transducing extracellular growth stimuli into early G1 mitogenic signals. In the present study, we investigated the role of Ras during the late stage of the G1 phase by using NIH 3T3 (M17) fibroblasts in which the expression of a dominant negative Ras mutant, p21(Ha-Ras[Asn17]), is induced in response to dexamethasone treatment. We found that delaying the expression of Ras(Asn17) until late in the G1 phase by introducing dexamethasone 3 h after the addition of epidermal growth factor (EGF) abolished the downregulation of the p27kip1 cyclin-dependent kinase (CDK) inhibitor which normally occurred during this period, with resultant suppression of cyclin Ds/CDK4 and cyclin E/CDK2 and G1 arrest. The immunodepletion of p27kip1 completely eliminated the CDK inhibitor activity from EGF-stimulated, dexamethasone-treated cell lysate. The failure of p27kip1 downregulation and G1 arrest was also observed in cells in which Ras(Asn17) was induced after growth stimulation with a phorbol ester or alpha-thrombin and was mimicked by the addition late in the G1 phase of inhibitors for phosphatidylinositol-3-kinase. Ras-mediated downregulation of p27kip1 involved both the suppression of synthesis and the stimulation of the degradation of the protein. Unlike the earlier expression of Ras(Asn17) at the border between G0 and G1, its delayed expression did not compromise the EGF-stimulated transient activation of extracellular signal-regulated kinases or inhibit the stimulated expression of a principal D-type cyclin, cyclin D1, until close to the border between G1 and S. We conclude that Ras plays temporally distinct, phase-specific roles throughout the G1 phase and that Ras function late in G1 is required for p27kip1 downregulation and passage through the restriction point, a prerequisite for entry into the S phase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271412      PMCID: PMC232385          DOI: 10.1128/MCB.17.9.5348

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells.

Authors:  T Satoh; M Endo; M Nakafuku; S Nakamura; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  An essential G1 function for cyclin-like proteins in yeast.

Authors:  H E Richardson; C Wittenberg; F Cross; S I Reed
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

3.  Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells.

Authors:  H Cai; J Szeberényi; G M Cooper
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

4.  Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells.

Authors:  J Szeberényi; H Cai; G M Cooper
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

5.  Genetic control of the cell division cycle in yeast.

Authors:  L H Hartwell; J Culotti; J R Pringle; B J Reid
Journal:  Science       Date:  1974-01-11       Impact factor: 47.728

6.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells.

Authors:  S Cowley; H Paterson; P Kemp; C J Marshall
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

7.  Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.

Authors:  L S Mulcahy; M R Smith; D W Stacey
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

8.  Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP).

Authors:  J B Gibbs; M S Marshall; E M Scolnick; R A Dixon; U S Vogel
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

9.  Cell cycle arrest caused by CLN gene deficiency in Saccharomyces cerevisiae resembles START-I arrest and is independent of the mating-pheromone signalling pathway.

Authors:  F R Cross
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

10.  Role of Ca2+ influx in bombesin-induced mitogenesis in Swiss 3T3 fibroblasts.

Authors:  N Takuwa; A Iwamoto; M Kumada; K Yamashita; Y Takuwa
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

View more
  36 in total

1.  The kinetic origins of the restriction point in the mammalian cell cycle.

Authors:  B D Aguda; Y Tang
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

2.  Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors.

Authors:  D M Gitig; A Koff
Journal:  Mol Biotechnol       Date:  2001-10       Impact factor: 2.695

3.  Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells.

Authors:  M Kortylewski; P C Heinrich; M E Kauffmann; M Böhm; A MacKiewicz; I Behrmann
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

4.  The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras.

Authors:  Jose Luis Oliva; Dolores Pérez-Sala; Antonio Castrillo; Natalia Martínez; F Javier Cañada; Lisardo Boscá; José M Rojas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

5.  Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts.

Authors:  N Takuwa; Y Fukui; Y Takuwa
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.

Authors:  D M Li; H Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 7.  New insights into the tumor suppression function of P27(kip1)

Authors:  B E Clurman; P Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

8.  Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.

Authors:  J S Foster; D C Henley; A Bukovsky; P Seth; J Wimalasena
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 9.  p27 deregulation in breast cancer: prognostic significance and implications for therapy.

Authors:  A Alkarain; R Jordan; J Slingerland
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

10.  Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: is it a good predictor for tumor behavior?

Authors:  Latife Doganay; Semsi Altaner; Selcuk Bilgi; Esat Kaya; Galip Ekuklu; Kemal Kutlu
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.